CBio
Biopharmaceutical company providing TIL immunotherapies, ATMPs, and clinical-stage treatments for cancer patients.
1
Funding Rounds
$1.6m
Money raised
Overview
Biopharmaceutical company providing TIL immunotherapies, ATMPs, and clinical-stage treatments for cancer patients.
- Website:
- Business model: B2B
- Headquarters: Copenhagen
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company CBio has raised a total of $1.6m in funding over 1 rounds.
Key Insights:
- CBio October 2021 Funding Round: $1.6m
CBio October 2021 Funding Round
$1.6m
Industries
CBio is active in the following industries: